Skip to main content
. 2012 Nov 30;14(1):83. doi: 10.1186/1532-429X-14-83

Table 1.

Baseline Patient Characteristics

Characteristic All patients n=71 MI n=46 No MI n=25 P value
Age - years
 Mean ± standard deviation
57.9 ± 11.1
59.9 ± 9.9
54.2 ± 12.6
0.04
 Maximum, minimum
28, 83
38, 83
28,80
 
Male sex – no (%)
52 (73)
35 (76)
17 (68)
0.47
CAD Risk Factors – no (%)
 Family history
12 (17)
8 (17)
4 (16)
0.89
 Hypertension
49 (69)
37 (80)
12 (48)
0.006
 Dyslipidemia
49 (69)
40 (87)
9 (36)
< 0.0001
 Diabetes
15 (21)
14 (30)
1 (4)
0.012
 Smoking
27 (38)
20 (57)
7 (28)
0.21
Known CAD – no (%)
38 (54)
37 (80)
1 (4)
<0.0001
>3 CAD Risk Factors- no (%)
21 (30)
18 (39)
3 (12)
0.002
Medications (%)
 Anti-platelets/anti coagulants
 Aspirin
49 (69)
41 (89)
8 (32)
<0.0001
 Clopidogrel/Prasugrel
18 (25)
18 (39)
0 (0)
0.0004
 Warfarin
4 (6)
3 (7)
1 (4)
0.69
 Anti-hypertensives
 Beta blocker
48 (68)
39 (85)
9 (36)
<0.0001
 Calcium channel blocker
8 (11)
5 (11)
3 (12)
0.89
 ACE inhibitor
28 (39)
21 (46)
7 (28)
0.16
 ARB
9 (13)
8 (17)
1 (4)
0.12
 Diuretic
15 (21)
9 (20)
6 (24)
0.67
 Long acting nitrates
6 (8)
6 (13)
0 (0)
0.08
 Lipid Medications
 Statin
44 (62)
38 (83)
6 (24)
< 0.0001
 Other lipid therapy
8 (11)
5 (11)
3 (12)
0.89
 Diabetes Medications
 Insulin
7 (10)
7 (15)
0 (0)
0.052
 Oral diabetes agents
11 (16)
10 (22)
1 (4)
0.059
 No Cardiovascular Medications
9 (13)
1 (2)
8 (32)
0.0002
Left ventricular ejection fraction %
 Median, interquartile range
56, 15
51, 20
60,8
0.002
Indication for scan (%)
 Ischemia Assessment with Stress
37 (52)
22 (48)
15 (60)
0.34
 Viability
22 (31)
22 (48)
0 (0)
<0.0001
 Other
12 (17)
2 (4)
10 (40)
0.0002
Nonischemic cardiomyopathy
7 (10)
1 (2)
6 (24)
 
Aorta
3 (4)
1 (2)
2 (8)
 
Congenital 2 (3) 0 (0) 2 (8)